MicroRNAs Based Therapy of Hypertrophic Cardiomyopathy: The Road Traveled So Far

Hypertrophic cardiomyopathy (HCM) is an autosomal dominant disease characterized by variable expressivity, age penetrance, and a high heterogeneity. The transcriptional profile (miRNAs, mRNAs), epigenetic modifications, and posttranslational modifications seem to be highly relevant for the onset of...

Descripción completa

Detalles Bibliográficos
Autores principales: Roma-Rodrigues, Catarina, Raposo, Luís R., Fernandes, Alexandra R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609405/
https://www.ncbi.nlm.nih.gov/pubmed/26504850
http://dx.doi.org/10.1155/2015/983290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609405/
https://www.ncbi.nlm.nih.gov/pubmed/26504850
http://dx.doi.org/10.1155/2015/983290

Ejemplares similares